Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | RGS12 | O14924 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14771663 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL14771667 | 1.00 | ALDH1A1 (0.51) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL6248391 | 0.85 | CYP3A4 (0.46) | ALDH1A1CYP3A4TSHRCYP2C19HSD17B10 | |
| SCHEMBL28360980 | 0.83 | CYP3A4 (0.51) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL12199933 | 0.83 | CYP3A4 (0.58) | ALDH1A1CYP3A4TSHRCYP2D6HSD17B10 | |
| Acetic Acid SCHEMBL11356631 | 0.83 | ALDH1A1 (0.55) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL14771681 | 0.82 | CYP3A4 (0.46) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL14771672 | 0.82 | CYP3A4 (0.46) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL14771654 | 0.82 | TSHR (0.46) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A | |
| SCHEMBL11142451 | 0.82 | TSHR (0.46) | ALDH1A1CYP3A4TSHRCHRM2ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11857684-B2 | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof | BAYER HEALTHCARE LLC (US) | 2024-01-02 | — | — | US | disclosed |
| US-11857684-B2 | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof | BAYER HEALTHCARE LLC (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2022103620-A1 | ORAL BILAYER TABLETS COMPRISING ACETYLSALICYLIC ACID AND PSEUDOEPHEDRINE, METHODS OF PREPARING AND USING THEREOF | BAYER HEALTHCARE LLC (US) | 2022-05-19 | — | — | WO | disclosed |
| US-20220151936-A1 | ORAL BILAYER TABLETS COMPRISING ACETYLSALICYLIC ACID AND PSEUDOEPHEDRINE, METHODS OF PREPARING AND USING THEREOF | BAYER HEALTHCARE LLC (US) | 2022-05-19 | — | — | US | disclosed |
| US-20080293971-A1 | A Process for the Preparation of R-(-)-N, Alpha-Dimethylphenethylamine (Levmethamfetamine) or S-(+)-N, Alpha-Dimethylphenethylamine (Methamphetamine) from D-Ephendrine, or L-Ephedrine Respectively | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2008-11-27 | — | — | US | disclosed |
| EP-1828105-B1 | A PROCESS FOR THE PREPARATION OF R-(-)-N, ALPHA-DIMETHYLPHENETHYLAMINE (LEVMETAMFETAMINE) OR S-(+)-N, ALPHA-DIMETHYLPHENETHYLAMINE (METHAMPHETAMINE) FROM d-EPHEDRINE OR L-EPHEDRINE RESPECTIVELY | EMMELLEN BIOTECH PHARMACEUTICA (IN) | 2008-09-03 | — | — | EP | disclosed |
| EP-1828105-A1 | A PROCESS FOR THE PREPARATION OF R-(-)-N, ALPHA-DIMETHYLPHENETHYLAMINE (LEVMETAMFETAMINE) OR S-(+)-N, ALPHA-DIMETHYLPHENETHYLAMINE (METHAMPHETAMINE) FROM d-EPHEDRINE OR L-EPHEDRINE RESPECTIVELY | Emmellen Biotech Pharmaceuticals Limited (IN) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006067794-A1 | A PROCESS FOR THE PREPARATION OF R-(-)-N, α-DIMETHYLPHENETHYLAMINE (LEVMETAMFETAMINE) OR S-(+)-N, α-DIMETHYLPHENETHYLAMINE (METHAMPHETAMINE) FROM d-EPHEDRINE OR L-EPHEDRINE RESPECTIVELY | EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (IN) | 2006-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220151936-A1 | ORAL BILAYER TABLETS COMPRISING ACETYLSALICYLIC ACID AND PSEUDOEPHEDRINE, METHODS OF PREPARING AND USING THEREOF | PTGDR, PLA2G7, PTGIR | ALDH1A1 3274/4885CYP3A4 307/4885TSHR 4326/4885 |
| US-20080293971-A1 | A Process for the Preparation of R-(-)-N, Alpha-Dimethylphenethylamine (Levmethamfetamine) or S-(+)-N, Alpha-Dimethylphenethylamine (Methamphetamine) from D-Ephendrine, or L-Ephedrine Respectively | HNMT, DDT, METTL3 | ALDH1A1 252/4885CYP3A4 468/4885TSHR 2976/4885 |
| US-11857684-B2 | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof | PTGDR, PLA2G7, PTGIR | ALDH1A1 3274/4885CYP3A4 307/4885TSHR 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.